Utility of ICD Codes for Stress Cardiomyopathy in Hospital Administrative Databases: What Do They Signify?
Journal
Journal of hospital medicine
ISSN: 1553-5606
Titre abrégé: J Hosp Med
Pays: United States
ID NLM: 101271025
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
revised:
16
10
2019
received:
17
05
2019
accepted:
20
10
2019
pubmed:
24
12
2019
medline:
24
12
2019
entrez:
24
12
2019
Statut:
ppublish
Résumé
Prior studies of stress cardiomyopathy (SCM) have used International Classification of Diseases (ICD) codes to identify patients in administrative databases without evaluating the validity of these codes. Between 2010 and 2016, we identified 592 patients discharged with a first known principal or secondary ICD code for SCM in our medical system. On chart review, 580 charts had a diagnosis of SCM (positive predictive value 98%; 95% CI: 96.4-98.8), although 38 (6.4%) did not have active clinical manifestations of SCM during the hospitalization. Moreover, only 66.8% underwent cardiac catheterization and 91.5% underwent echocardiography. These findings suggest that, although all but a few hospitalized patients with an ICD code for SCM had a diagnosis of SCM, some of these were chronic cases, and numerous patients with a new diagnosis of SCM did not undergo a complete diagnostic workup. Researchers should be mindful of these limitations in future studies involving administrative databases.
Identifiants
pubmed: 31869294
pii: jhm.3344
doi: 10.12788/jhm.3344
pmc: PMC7064300
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
160-163Subventions
Organisme : NHLBI NIH HHS
ID : K01 HL114745
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL135440
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL132008
Pays : United States
Organisme : NHLBI NIH HHS
Pays : United States
Organisme : NIH HHS
ID : 1K23HL135440
Pays : United States
Organisme : NHLBI NIH HHS
Pays : United States
Organisme : NIH HHS
ID : K01HL114745
Pays : United States
Organisme : NHLBI NIH HHS
Pays : United States
Organisme : NIH HHS
ID : 1K24HL132008
Pays : United States
Informations de copyright
© 2020 Society of Hospital Medicine.
Références
Khera R, Light-McGroary K, Zahr F, Horwitz PA, Girotra S. Trends in hospitalization for takotsubo cardiomyopathy in the United States. Am Heart J. 2016;172:53-63. https://doi.org/10.1016/j.ahj.2015.10.022.
Murugiah K, Wang Y, Desai NR, et al. Trends in short- and long-term outcomes for takotsubo cardiomyopathy among medicare fee-for-service beneficiaries, 2007 to 2012. JACC Heart Fail. 2016;4(3):197-205. https://doi.org/10.1016/j.jchf.2015.09.013.
Brinjikji W, El-Sayed AM, Salka S. In-hospital mortality among patients with takotsubo cardiomyopathy: a study of the National Inpatient Sample 2008 to 2009. Am Heart J. 2012;164(2):215-221. https://doi.org/10.1016/j.ahj.2012.04.010.
Smilowitz NR, Hausvater A, Reynolds HR. Hospital readmission following takotsubo syndrome. Eur Heart J Qual Care Clin Outcomes. 2018;5(2):114-120. https://doi.org/10.1093/ehjqcco/qcy045.
Vallabhajosyula S, Deshmukh AJ, Kashani K, Prasad A, Sakhuja A. Tako-Tsubo cardiomyopathy in severe sepsis: nationwide trends, predictors, and outcomes. J Am Heart Assoc. 2018;7(18):e009160. https://doi.org/10.1161/JAHA.118.009160.
Shaikh N, Sardar M, Jacob A, et al. Possible predictive factors for recovery of left ventricular systolic function in takotsubo cardiomyopathy. Intractable Rare Dis Res. 2018;7(2):100-105. https://doi.org/10.5582/irdr.2018.01042.
Shah M, Ram P, Lo KBU, et al. Etiologies, predictors, and economic impact of readmission within 1 month among patients with takotsubo cardiomyopathy. Clin Cardiol. 2018;41(7):916-923. https://doi.org/10.1002/clc.22974.
Misumida N, Ogunbayo GO, Kim SM, Abdel-Latif A, Ziada KM, Sorrell VL. Clinical outcome of takotsubo cardiomyopathy diagnosed with or without coronary angiography. Angiology. 2019;70(1):56-61. https://doi.org/10.1177/0003319718782049.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. https://doi.org/10.1016/0021-9681(87)90171-8.
Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27. https://doi.org/10.1097/00005650-199801000-00004.
Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. Sep 3 2015;373(10):929-938. https://doi.org/10.1056/NEJMoa1406761.
Medina de Chazal H, Del Buono MG, Keyser-Marcus L, et al. Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(16):1955-1971. https://doi.org/10.1016/j.jacc.2018.07.072.
Ghadri JR, Wittstein IS, Prasad A, et al. international expert consensus document on takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J. 2018;39(22):2032-2046. https://doi.org/10.1093/eurheartj/ehy076.